Recently, the interleukin (IL) receptor-associated protein 1 (IRAP1) was detected specifically on BCR-ABL mutated, but not on normal HSCs [43], and also was detected in stem and progenitor cells of AML patients [44], thus opening the path to use it for specific detection of cancer-initiating cells and targeted treatment. The gene discussed is ABL1; the disease is cancer.